Robert McNamara Acquires 11,000 Shares of AVITA Medical, Inc. (ASX:AVH) Stock
by Kim Johansen · The Markets DailyAVITA Medical, Inc. (ASX:AVH – Get Free Report) insider Robert McNamara acquired 11,000 shares of AVITA Medical stock in a transaction dated Friday, March 7th. The shares were acquired at an average price of A$8.30 ($5.25) per share, with a total value of A$91,300.00 ($57,784.81).
Robert McNamara also recently made the following trade(s):
- On Friday, February 21st, Robert McNamara bought 10,000 shares of AVITA Medical stock. The stock was purchased at an average price of A$10.09 ($6.39) per share, with a total value of A$100,900.00 ($63,860.76).
AVITA Medical Price Performance
The stock has a market capitalization of $226.55 million, a price-to-earnings ratio of -5.55 and a beta of 1.54. The company has a debt-to-equity ratio of 0.36, a current ratio of 8.18 and a quick ratio of 9.32.
About AVITA Medical
AVITA Medical, Inc, together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions.
Further Reading
- Five stocks we like better than AVITA Medical
- Insider Trading – What You Need to Know
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- What to Know About Investing in Penny Stocks
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Manufacturing Stocks Investing
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?